FDA Launched Recruitment for Advisory Committee Members

The agency is seeking experts and consumer representatives to provide guidance across various medical fields.

Updated on Sept. 30, 2026 in Cancer

Isometric editorial illustration of medical vials and analytical lenses, representing expert evaluation and the FDA's committee recruitment process. — The U.S. Food and Drug Administration has launched a nationwide recruitment drive for new members to join its advisory committees across medical disciplines. AI Illustration. Upload story photo >

Live Poll

Should federal health agencies prioritize consumer voices equally with scientific experts on advisory committees?

The U.S. Food and Drug Administration has initiated a nationwide search to fill advisory committee vacancies. The agency is looking for scientific, technical, and professional voting members as well as consumer representatives to provide critical independent expertise.

Why it matters

Broadening participation on these committees allows the FDA to maintain rigorous scientific scrutiny across complex medical disciplines. This recruitment effort ensures the agency has access to specialized knowledge when evaluating new health technologies and treatments.

Advisory committee members serve terms of up to 4 years, with the FDA managing vacancies on a continuous basis. The agency is specifically targeting roles in oncology, cardiovascular medicine, neurology, genetics, and medical devices.

The players

U.S. Food and Drug Administration

The federal agency responsible for protecting public health by ensuring the safety and efficacy of human drugs, biological products, and medical devices.

The details

The FDA published two notices in the Federal Register to solicit nominations from the public and the scientific community. Interested candidates can apply for these roles through the centralized FDA Advisory Committee Membership Nomination portal.

September 30, 2026: The FDA announced the new recruitment effort.
November 15, 2026: Deadline for consumer representative nominations.
November 30, 2026: Deadline for scientific and technical voting member nominations.

Biotech
Sept. 23
Heidi Overton Will Address Senate on FDA Strategy
Cancer
Sept. 18
FDA Released Streamlined Drug Testing Guidance
Nutrition
Sept. 20
Senate Scheduled FDA Nominee Confirmation Hearing

Health Landscape

This recruitment drive updates the active roster of the FDA's independent advisory committee structure to ensure continued oversight of medical innovation. These panels serve as the primary mechanism for external expert review, ensuring that regulatory decisions are grounded in rigorous scientific consensus.

By filling these advisory roles, the FDA ensures that patient-focused expertise informs the approval process for new oncology and neurological treatments. These committee members help shape the safety standards that ultimately influence the quality of care available to patients nationwide.

The takeaway

The FDA relies on external experts to maintain high standards of scrutiny for the U.S. healthcare system. Qualified professionals interested in public service can contribute to this process by monitoring official agency postings for future committee openings.

What happens next

The FDA will continue to accept nominations for future committee vacancies beyond the initial November 2026 deadlines as needs arise within the agency.